Literature DB >> 15539409

Role of hepatocyte nuclear factors in transcriptional regulation of male-specific CYP2A2.

Christopher A Wiwi1, David J Waxman.   

Abstract

Cytochrome P450 2A2 (CYP2A2) is an adult male-specific rat liver steroid hydroxylase whose sex-dependent expression is regulated at the transcriptional level by sexually dimorphic pituitary growth hormone (GH) secretory patterns. In contrast to CYP2C11 and other male-specific, plasma GH pulse-inducible liver genes, CYP2A2 is highly expressed in hypophysectomized rat liver, despite the absence of GH stimulation. CYP2A2 promoter fragments 0.9-6.2 kb long exhibited unusually high basal promoter activity when transfected into the liver cell line HepG2. A further approximately 2.5-fold increase in activity was obtained by cotransfection of hepatocyte nuclear factor (HNF) 3gamma or HNF4alpha. CYP2A2 promoter activity was inhibited approximately 85% by transfection of HNF3beta or HNF6, both of which are more highly expressed in female than male liver and can strongly trans-activate the female-specific CYP2C12 promoter. The male GH pulse-activated transcription factor STAT5b had no effect on CYP2A2 promoter activity, either alone or in combination with HNF3gamma and HNF4alpha, consistent with the GH pulse-independence of CYP2A2 expression. By contrast, STAT5b synergistically enhanced the transcriptional activity of HNF4alpha toward two other male-specific liver target genes, Cyp2d9 and CYP8B1. Furthermore, STAT5b in combination with the HNF4alpha coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha strongly enhanced the transcriptional activity of HNF4alpha toward CYP8B1 but not toward CYP2A2. These findings support the hypothesis that sex-dependent HNFs contribute to the sexually dimorphic expression of CYP2A2 and other liver CYPs and highlight the ability of STAT5b to act in concert with HNF4alpha to regulate select male-specific liver CYP genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539409     DOI: 10.1074/jbc.M409294200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The KRAB zinc finger protein RSL1 regulates sex- and tissue-specific promoter methylation and dynamic hormone-responsive chromatin configuration.

Authors:  Christopher J Krebs; David C Schultz; Diane M Robins
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

2.  Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.

Authors:  Xuxu Sun; Sam C Wang; Yonglong Wei; Xin Luo; Yuemeng Jia; Lin Li; Purva Gopal; Min Zhu; Ibrahim Nassour; Jen-Chieh Chuang; Thomas Maples; Cemre Celen; Liem H Nguyen; Linwei Wu; Shunjun Fu; Weiping Li; Lijian Hui; Feng Tian; Yuan Ji; Shuyuan Zhang; Mahsa Sorouri; Tae Hyun Hwang; Lynda Letzig; Laura James; Zixi Wang; Adam C Yopp; Amit G Singal; Hao Zhu
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

Review 3.  Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism.

Authors:  Myunggi Baik; Ji Hoon Yu; Lothar Hennighausen
Journal:  Ann N Y Acad Sci       Date:  2011-07       Impact factor: 5.691

4.  Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence.

Authors:  Danielle Duma; Jennifer B Collins; Jeff W Chou; John A Cidlowski
Journal:  Sci Signal       Date:  2010-10-12       Impact factor: 8.192

5.  Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.

Authors:  Soo-Hee Park; Christopher A Wiwi; David J Waxman
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

6.  Dynamic in vivo binding of STAT5 to growth hormone-regulated genes in intact rat liver. Sex-specific binding at low- but not high-affinity STAT5 sites.

Authors:  Ekaterina V Laz; Aarathi Sugathan; David J Waxman
Journal:  Mol Endocrinol       Date:  2009-05-07

7.  Mechanism of gender-divergent UDP-glucuronosyltransferase mRNA expression in mouse liver and kidney.

Authors:  David B Buckley; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2009-01-08       Impact factor: 3.922

Review 8.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

9.  Characterization of three growth hormone-responsive transcription factors preferentially expressed in adult female liver.

Authors:  Ekaterina V Laz; Minita G Holloway; Chong-Sheng Chen; David J Waxman
Journal:  Endocrinology       Date:  2007-04-05       Impact factor: 4.736

10.  Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing.

Authors:  Elizabeth D Wederell; Mikhail Bilenky; Rebecca Cullum; Nina Thiessen; Melis Dagpinar; Allen Delaney; Richard Varhol; YongJun Zhao; Thomas Zeng; Bridget Bernier; Matthew Ingham; Martin Hirst; Gordon Robertson; Marco A Marra; Steven Jones; Pamela A Hoodless
Journal:  Nucleic Acids Res       Date:  2008-07-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.